MedPath

A comparitive study of efficacy of two different drug combination in reducing adverse events due to the process of insertion of endotracheal tube into the larynx in hypertensive patient

Phase 4
Conditions
Health Condition 1: I10- Essential (primary) hypertensionHealth Condition 2: I10- Essential (primary) hypertensionHealth Condition 3: I10- Essential (primary) hypertension
Registration Number
CTRI/2021/10/037562
Lead Sponsor
vijaynagar institute of medical sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.ASA physical status II

2.Patients with normal ( modified Mallampatti class I or II )

Exclusion Criteria

1.refusal by patients for the procedure

2.ASA physical status 3 and 4

3.uncontrolled hypertension ( >160/90mmhg)

4.patient with the history of hypersensitivity to inj propofol and inj etomidate

5.Anticipated difficult airway

6.patient with cardiovascular diseases other than hypertension, epilepsy, renal, hepatic disease

7.Brochial asthma and COPD

8.presence of known primary or secondary adrenal insufficiency or on steroid medication

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath